FDA product code LJX: Test, Urine Leukocyte
LJX is the FDA product code for test, urine leukocyte. It is a Class I device, regulated under 21 CFR 864.7675 and reviewed by the Hematology panel. FDA has cleared 7 510(k) submissions under LJX, 1 in the last five years, from 6 different applicants. The average 510(k) review took 94 days (median 65). FDA has posted 5 recalls for LJX devices, 3 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Test, Urine Leukocyte |
| Device class | Class I |
| Regulation | 21 CFR 864.7675 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) exempt |
510(k) clearances per year for LJX
| Year | Clearances | Avg. review days |
|---|---|---|
| 2023 | 1 | 65 |
Compare with all 510(k) review times · Search every LJX clearance
Top LJX applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Miles Laboratories, Inc. | 2 | 1987-09-11 |
| Healgen Scientific,, LLC | 1 | 2023-06-16 |
| ACON Laboratories, Inc. | 1 | 2007-10-12 |
| Serim Research Corp. | 1 | 2000-05-05 |
| Chronimed, Inc. | 1 | 1998-06-01 |
1 more applicants have LJX clearances. See the full list in Caduvo.
Most recent LJX clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K231045 | Healgen Scientific,, LLC | Healgen URS Test Strips | 2023-06-16 | 65 |
| K063295 | ACON Laboratories, Inc. | ACON UTI URINARY TRACT INFECTION TEST STRIPS | 2007-10-12 | 345 |
| K000578 | Serim Research Corp. | SERIM LEUKOCYTE ESTERASE TEST STRIPS | 2000-05-05 | 73 |
| K981555 | Chronimed, Inc. | DIASCREEN REAGENT STRIPS | 1998-06-01 | 31 |
| K971976 | Dia-Screen Corp. | DIASCREEN REAGENT STRIPS | 1997-06-17 | 19 |
Recalls for LJX devices
5 product recalls in 5 recall events; 3 initiated in the last five years and 3 still open. Most recent: 2026-04-02.
| Year | Recalls |
|---|---|
| 2017 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Frequently asked questions
What is FDA product code LJX?
LJX is the FDA product code for test, urine leukocyte. It is a Class I device, regulated under 21 CFR 864.7675 and reviewed by the Hematology panel.
What device class is LJX?
Class I, regulation 21 CFR 864.7675. Typical premarket route: 510(k) exempt.
How long does a 510(k) take for product code LJX?
Across 7 cleared submissions the average was 94 days from receipt to decision (median 65).
Which companies have the most LJX clearances?
Miles Laboratories, Inc. (2); Healgen Scientific,, LLC (1); ACON Laboratories, Inc. (1); Serim Research Corp. (1); Chronimed, Inc. (1).
Have LJX devices been recalled?
Yes: 5 product recalls across 5 recall events; the most recent began 2026-04-02.
Next steps
- Run an FDA pathway report with predicate devices for product code LJX
- Run a recall and safety report across every LJX manufacturer
- Watch product code LJX for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times